DEC 06, 2017 09:33 AM PST

Mutations in the Immune System Increase Risk of Hodgkin Lymphoma

WRITTEN BY: Kara Marker

A first-of-its-kind study reveals genetic variants in the immune system that increase the risk of Hodgkin lymphoma, a type of cancer that commonly affects young adults. From the Institute of Cancer research, scientists pave the way for potential new treatments based on these genetic changes.

Histopathologic image of Hodgkin's lymphoma, lymph node biopsy. Credit: Wikimedia user KGH

Hodgkin lymphoma is a cancer defined by the abnormal growth and proliferation of lymphocytes, These are immune cells such as B cells and T cells, with the cancer usually beginning in B cells, which produce antibodies. First-line therapies successfully clear out cancer for most patients, but for those that need more, these new findings might be helpful. About 80 percent of people who develop Hodgkin lymphoma survive in the long-term, but sometimes treatment for this type of cancer results in long-term effects; new and better treatments could make survival rates even higher and lower the prevalence of long-term side effects.

In the new study, researchers completed an analysis of genetic data from 5,314 cases of Hodgkin lymphoma and 16,749 controls. They identified six genetic variations with just one letter change, meaning the A, G, T, and C nucleotides that make up DNA. Five of these changes impact the way B cells develop and increase the risk of lymphoma by 15 to 30 percent. Three have already been associated with autoimmune diseases like multiple sclerosis, rheumatoid arthritis, and lupus in the past.

"It doesn't mean that if you develop an autoimmune disease you are at increased risk of lymphoma, but it does offer fascinating genetic clues to these diseases,” explained Richard Houlston. “The new information could point towards new ways of diagnosing, treating, or even helping to prevent Hodgkin lymphoma."

The study’s results also indicated that different genetic variants are associated with risk of different types of Hodgkin lymphoma, such as nodular sclerosis Hodgkin lymphoma and mixed cellularity Hodgkin lymphoma.

"Understanding the genetic changes that underpin cancer's development is crucial for all aspects of our quest to defeat cancer,” explained Paul Workman. “To understand which patients are most at risk from different types of cancer, to improve diagnosis, and to develop treatments that are most likely to work for individual patients.”

The present study is published in the journal Nature Communications.

Sources: American Cancer Society, Institute of Cancer Research

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 03, 2018
Cardiology
MAY 03, 2018
Immune Cells and Heart Disease: Helpful or Harmful?
Depending on where an immune cell is during injury to the heart, like during a heart attack, their activity can either be harmful or helpful. From Case Wes...
MAY 11, 2018
Immunology
MAY 11, 2018
Successful Neural Stem Cell Therapy Without Immunosuppression
Neural stem cells designed to be identical to the host they were derived from are the newest hope for scientists in transplantation medicine, specifically...
JUN 02, 2018
Immunology
JUN 02, 2018
New Test Predicts Lupus Onset
Based on several different factors, scientists have a new risk index for predicting who will develop lupus. From the Feinstein Institute for Medical Resear...
JUN 18, 2018
Immunology
JUN 18, 2018
Detecting and Diagnosing Rheumatoid Arthritis Before it Begins
Unique gene signatures and tiny changes in the immune system that occur in the earliest stages of rheumatoid arthritis, an autoimmune disease, could soon b...
JUL 06, 2018
Cell & Molecular Biology
JUL 06, 2018
Small Molecules Found to Dial Down Autoimmunity
Scientists have now identified two combinations of small molecules that tamp down a protein called STING....
JUL 09, 2018
Immunology
JUL 09, 2018
Protein Complex Determines the Fate of T cells
The protein complex mTORC1 has been shown to integrate metabolic and signaling activity to determine the fate of T cell lineage between alpha beta and gamma delta....
Loading Comments...